[Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].

Nava Castañeda, A.; Tovilla Canales, J L; Garnica Hayashi, L; Velasco Y Levy, A

doi:10.1016/j.jfo.2016.10.016

Record: found
Abstract: found
Article: not found

[Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].

Author(s): A Nava Castañeda ¹ , J L Tovilla Canales ¹ , L Garnica Hayashi ¹ , A Velasco Y Levy ²

Publication date (Electronic): Apr 2017

Journal: Journal francais d'ophtalmologie

Publisher: Elsevier BV

Keywords: Botulinum toxin type A, Dysthyroid orbitopathy, Grave's disease, Maladie de Basedow, Ophtalmopathie dysthyroïdienne, Orbital inflammatory disease, Orbitopathie inflammatoire, Rétraction palpébrale supérieure, Toxine botulique A, Upper eyelid retraction

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the efficacy of transconjunctival botulinum toxin type A (BTX-A) in the treatment of upper eyelid retraction in the active inflammatory phase of dysthyroid orbitopathy, establish the ideal dose, and evaluate side effects.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Fr Ophtalmol

Title: Journal francais d'ophtalmologie

Publisher: Elsevier BV

ISSN (Electronic): 1773-0597

ISSN (Print): 0181-5512

Publication date (Electronic): Apr 2017

Volume: 40

Issue: 4

Affiliations

[1 ] Service d'orbite, paupières et voies lacrimales, institut d'ophtalmologie « Conde de Valenciana », Chimalpopoca 14, Ciudad de México, Mexique.

[2 ] Service d'orbite, paupières et voies lacrimales, institut d'ophtalmologie « Conde de Valenciana », Chimalpopoca 14, Ciudad de México, Mexique. Electronic address: dravelascoylevy@hotmail.com.

Article

Publisher Item ID: S0181-5512(17)30080-3

DOI: 10.1016/j.jfo.2016.10.016

PubMed ID: 28336282

SO-VID: 838dfe18-fccc-47a2-8889-29ea67ad6d08

History

Keywords: Botulinum toxin type A,Dysthyroid orbitopathy,Grave's disease,Maladie de Basedow,Ophtalmopathie dysthyroïdienne,Orbital inflammatory disease,Orbitopathie inflammatoire,Rétraction palpébrale supérieure,Toxine botulique A,Upper eyelid retraction

Data availability:

[Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].

Read this article at

Abstract

Related collections

Biomarkers for Inflammatory Lung Disease

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 61

Cited by 2